Schrödinger births new immunology and inflammation biotech, Tectora Therapeutics

Schrödinger announced the launch of new immune disease-focused Tectora Therapeutics, which comes online with a $55 million series A financing round.

source

Reporting by Fierce Biotech.

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

Fierce Biotech19h ago1 min read

Schrödinger announced the launch of new immune disease-focused Tectora Therapeutics, which comes online with a $55 million series A financing round.

source

Reporting by Fierce Biotech.

5-min edit window · permanent after that

no comments yet — first sniff?